ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2011 - 2026)
ClearPoint Neuro (CLPT) posted Depreciation & Amortization (CF) of $86000.0 for Q1 2026, down 65.46% sequentially from $249000.0 in Q4 2025, and down 16.5% YoY from $103000.0 in Q1 2025.
ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Depreciation & Amortization (CF) for 15 years, with the latest figure at $86000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 16.5% year-over-year to $86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $797000.0 (down 5.12% YoY) and the FY2025 annual result came in at $814000.0, down 16.94% from the prior year.
- Depreciation & Amortization (CF) eased to $86000.0 in Q1 2026 per CLPT's latest filing, from $249000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $396000.0 in Q2 2025 and troughed at $20000.0 in Q4 2022.
- A 5-year average of $161764.7 and a median of $156000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) surged 815.0% in 2023, then plunged 75.0% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $20000.0 in 2022, then soared by 815.0% to $183000.0 in 2023, then surged by 31.15% to $240000.0 in 2024, then increased by 3.75% to $249000.0 in 2025, then tumbled by 65.46% to $86000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $86000.0, $249000.0, and $66000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | ClearPoint Neuro | 465.77 Mn | 436.37 Mn | 6.71 Mn | 150,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150,000.00 |
| Jun 30, 2026 | 150,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Mar 31, 2024 | 243,000.00 |
| Mar 31, 2024 | 243,000.00 |